Pharmacokinetic dose adjustment of 5-FU in modified FOLFOX7 plus bevacizumab for metastatic colorectal cancer in Japanese patients: a-JUST phase II clinical trial
Crossref DOI link: https://doi.org/10.1007/s00280-016-3184-6
Published Online: 2016-11-02
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Denda, Tadamichi
Kanda, Mitsuro
Morita, Yoshitaka
Kim, Ho Min
Kashiwada, Tomomi
Matsuda, Chu
Fujieda, Shinji
Nakata, Ken
Murotani, Kenta
Oba, Koji
Sakamoto, Junichi
Mishima, Hideyuki
License valid from 2016-11-02